BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34380460)

  • 21. Epigenetic regulation of Dpp6 expression by Dnmt3b and its novel role in the inhibition of RA induced neuronal differentiation of P19 cells.
    Sheikh MA; Malik YS; Yu H; Lai M; Wang X; Zhu X
    PLoS One; 2013; 8(2):e55826. PubMed ID: 23409053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis.
    Li Y; Yan J; Wang Y; Wang C; Zhang C; Li G
    Cell Biochem Funct; 2020 Dec; 38(8):1079-1088. PubMed ID: 32526811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
    Ying Y; Li J; Xie H; Yan H; Jin K; He L; Ma X; Wu J; Xu X; Fang J; Wang X; Zheng X; Liu B; Xie L
    Cell Prolif; 2020 Feb; 53(2):e12751. PubMed ID: 31971654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S; Xu J; Wang H; Guo H
    Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Hibino S; Oya H; Takami H; Kobayashi D; Yamada S; Inokawa Y; Tanaka C; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Aug; 110(2):136-44. PubMed ID: 24700496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt7a, frequently silenced by CpG methylation, inhibits tumor growth and metastasis via suppressing epithelial-mesenchymal transition in gastric cancer.
    Liu Y; Qiao Y; Zhang H; Li W; Zheng J
    J Cell Biochem; 2019 Oct; 120(10):18142-18151. PubMed ID: 31144375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
    Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
    J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
    Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
    Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.
    Wisnieski F; Santos LC; Calcagno DQ; Geraldis JC; Gigek CO; Anauate AC; Chen ES; Rasmussen LT; Payão SLM; Artigiani R; Demachki S; Assumpção PP; Lourenço LG; Arasaki CH; Pabinger S; Krainer J; Leal MF; Burbano RR; Arruda Cardoso Smith M
    J Mol Med (Berl); 2020 May; 98(5):707-717. PubMed ID: 32285140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
    Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
    Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
    Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
    Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
    Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer.
    Li YC; Wang Y; Li DD; Zhang Y; Zhao TC; Li CF
    J Cell Biochem; 2018 Feb; 119(2):2440-2449. PubMed ID: 28926119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.
    Ghadami E; Nikbakhsh N; Fattahi S; Kosari-Monfared M; Ranaee M; Taheri H; Amjadi-Moheb F; Godazandeh G; Shafaei S; Nosrati A; Pilehchian Langroudi M; Samadani AA; Amirbozorgi G; Mirnia V; Akhavan-Niaki H
    J Cell Physiol; 2019 Apr; 234(4):4115-4124. PubMed ID: 30132887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.